Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corp (NQ: OMER )

3.080 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.080
Bid (Size) 2.900 (50)
Ask (Size) 3.180 (5)
Prev. Close 3.080
Today's Range 3.080 - 3.080
52wk Range 0.9200 - 7.798
Shares Outstanding 62,855,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OMER Stock Earnings: Omeros Misses EPS for Q4 2023
OMER stock results show that Omeros missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
From Omeros Corporation
Via Business Wire

Performance

YTD
-6.38%
-6.38%
1 Month
-10.47%
-10.47%
3 Month
-14.21%
-14.21%
6 Month
+175.00%
+175.00%
1 Year
-49.55%
-49.55%

More News

Read More
Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter
Via Benzinga
Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
From Omeros Corporation
Via Business Wire
Recap: Omeros Q3 Earnings
Via Benzinga
Earnings Preview: Omeros
Via Benzinga
Earnings Scheduled For April 1, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade
Via InvestorPlace
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
From Omeros Corporation
Via Business Wire
3 Sleeper Stocks Under $15 Ready to Explode by 2029
Via InvestorPlace
Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
From Omeros Corporation
Via Business Wire
7 Short-Squeeze Stocks That Are Screaming for Speculation
Via InvestorPlace
Top 5 Health Care Stocks That Are Ticking Portfolio Bombs
Via Benzinga
Insiders Buying Taysha Gene Therapies And 3 Other Stocks Under $2
Via Benzinga
Topics Stocks
Exposures US Equities
Omeros Corporation Reports Third Quarter 2023 Financial Results
From Omeros Corporation
Via Business Wire
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023
From Omeros Corporation
Via Business Wire
Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
From Omeros Corporation
Via Business Wire
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
From Omeros Corporation
Via Business Wire
Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer
From Omeros Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Crude Oil Moves Lower; Consolidated Communications Shares Jump
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.